CAS RN: 2128657-45-2
5H-Pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid, 3-bromo-6,6-difluoro-6,7-dihydro-, ethyl ester
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251124
100mg / 500mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2128657-45-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
2128657-45-2 / ethyl 3-bromo-6,6-difluoro-5,7-dihydropyrazolo[5,1-b][1,3]oxazine-2-carboxylate
Standard CAS: 2128657-45-2
Multi CAS: No
Basic Information
copy
CAS
2128657-45-2 copy
Multi CAS
No copy
Molecular Formula
C9H9BrF2N2O3 copy
Molecular Weight
311.080000 copy
Exact Mass
309.976460 copy
SMILES
CCOC(=O)C1=NN2CC(COC2=C1Br)(F)F copy
InChI
InChI=1S/C9H9BrF2N2O3/c1-2-16-8(15)6-5(10)7-14(13-6)3-9(11,12)4-17-7/h2-4H2,1H3 copy
InChIKey
PYKKGBVPQBHKQH-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
17 copy
Aromatic heavy atom count
5 copy
Fraction Csp3
0.56 copy
Rotatable bonds
2 copy
H-bond acceptors
5 copy
Molar refractivity
56.33 copy
TPSA
53.35 copy
LogP / Solubility
WLOGP
1.85 copy
MLOGP
1.64 copy
XLogP3
2.2 copy
Consensus LogP
1.9 copy
Log S (ESOL)
-3.02 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.45 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.46 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.3 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy